Financial barriers to immunotherapy: challenges and potential mitigation strategies: a review paper
Dose-optimization strategies can reduce costs without compromising clinical efficacy, especially where financial barriers threaten continuity of care. Priorities include, prospective trials validating reduced dosing and international partnerships to integrate LMICs into research.
Authors
- Arafat Tfayli (ORCID: https://orcid.org/0000-0002-0633-2538)
- Hasan Numan (ORCID: https://orcid.org/0009-0000-6063-2868)
Institutions
- American University of Beirut Medical Center (LB)
Publication Details
- Journal
- Immunotherapy
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1080/1750743x.2026.2639275
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00